Logo

People in the News: Brian Posner Joins BG Medicine's Board

Feb 17, 2012
Premium

BG Medicine this week announced the appointment of Brian Posner to its board of directors.

Posner is president of the consulting and advisory services firm Point Rider Group. Previously he was CEO and co-chief investment officer of ClearBridge Advisors. He also serves as a director at Biogen Idec, Arch Capital Group, and the AQR Funds.

Filed under

Proteomics & Protein Research
proteomics
BG Medicine
Breaking News
The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.